Search Results
Search results for "Aaron Sato"
Results found for "Aaron Sato"
Posts (14)
- Newly launched antibody libraries put hard-to-drug targets within reach
Aaron Sato, Chief Scientific Officer at Twist Bioscience, elaborates.
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Aaron McGrath from Takeda. He joins Dr. pockets and druggability 🔹 The role of cryo-EM in capturing fully activated GPCR complexes 📅 Catch Aaron
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Aaron McGrath from Takeda  🎥 Interview with Kris Borzilleri & Alison Heick Varghese from Pfizer 🎥
Other Pages (8)
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
Aaron Sato on building the synthetic antibody library that finally makes GPCRs tractable — and the greenfield strategy that led him there. << Back to podcast list Strategic Partner(s) Aaron Sato: Synthetic Antibody Aaron Sato, CSO of Twist Biopharma, describes the motif-directed library his team developed by collecting Aaron Sato from Twist Biopharma , a vertical within Twist Bioscience . Aaron Sato on the web LinkedIn Twitter Google Scholar Twist Bioscience Twist Biopharma Dr.
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
Kathleen Caron About Kathleen M. Caron Kathleen M. Caron, Ph.D. is the Frederik L. Caron received a BS in Biology and BA in Philosophy at Emory University and a PhD at Duke University Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Caron on the web Lab Website Twitter Pubmed Google Scholar Orcid Unlock the Full Dr.
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
His numerous awards include: 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical
